Back to Search

PATRICK BAUMANN, M.D.

M.D.

Internal Medicine Physician

NPI: 1114365384IndividualAccepts Medicare

Specialties, Licenses & Credentials

Internal Medicine PhysicianPrimary

Internal Medicine

Code: 207R00000X

49487(KY)

CMS Specialties

PrimaryHOSPITALIST

Additional

INTERNAL MEDICINE

Education

UNIVERSITY OF LOUISVILLE SCHOOL OF MEDICINE

Class of 2013

Research & Publications (20)

Steady-state concentrations of mirtazapine, N-desmethylmirtazapine, 8-hydroxymirtazapine and their enantiomers in relation to cytochrome P450 2D6 genotype, age and smoking behaviour.
PMID 19071885·Clin Pharmacokinet·2009
4-observational
Drug-induced Pisa syndrome under quetiapine.
PMID 19646500·Prog Neuropsychopharmacol Biol Psychiatry·2009
5-case
Cardiac left bundle branch block and pancytopenia in anorexia nervosa: higher risk with mirtazapine and pantoprazole? Case report.
PMID 19308886·Pharmacopsychiatry·2009
5-case
Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting, March 2008, Nice.
PMID 19411165·Eur Neuropsychopharmacol·2009
8-other
ABCB1 and cytochrome P450 polymorphisms: clinical pharmacogenetics of clozapine.
PMID 19593168·J Clin Psychopharmacol·2009
3-trial
The peptide-semicarbazone S-2209, a representative of a new class of proteasome inhibitors, induces apoptosis and cell growth arrest in multiple myeloma cells.
PMID 19170678·Br J Haematol·2009
7-preclinical
Dihydroorotate dehydrogenase inhibitor A771726 (leflunomide) induces apoptosis and diminishes proliferation of multiple myeloma cells.
PMID 19174558·Mol Cancer Ther·2009
8-other
The novel orally bioavailable inhibitor of phosphoinositol-3-kinase and mammalian target of rapamycin, NVP-BEZ235, inhibits growth and proliferation in multiple myeloma.
PMID 19071109·Exp Cell Res·2009
8-other
Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy.
PMID 19414667·J Clin Oncol·2009
3-trial
Myeloma cell growth inhibition is augmented by synchronous inhibition of the insulin-like growth factor-1 receptor by NVP-AEW541 and inhibition of mammalian target of rapamycin by Rad001.
PMID 19240643·Anticancer Drugs·2009
8-other

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Request Appointment

Contact & Hours

Address
3950 KRESGE WAY, #308
LOUISVILLE, KY 40207

Quick Facts

NPI
1114365384
Entity Type
Individual
Gender
Male
Medicare
Accepted
Specialties
1
Locations
1
Years in Practice
13
Publications
20

Are you this provider?

Claim Your Profile